Research
Hormonal
Adjuvant GLP-1RA users achieved a higher mean proportion of days covered (PDC) of 74.30% compared to 66.91% for SGA-only users.
Incorporating GLP-1RA may enhance medication adherence in patients prescribed SGAs.
StrongSupportsmedium confidence
adjuvant GLP-1-RA users achieved a higher mean proportion of days covered (PDC; 74.30% vs 66.91%)
Why this rating
Based on the retrospective cohort study design with a large sample size.
Source
Impact of Adjuvant GLP-1RA Treatment on the Adherence of Second-Generation Antipsychotics in Nondiabetic Adults
Jerusha Daggolu et al. · Journal of Clinical Psychopharmacology · 2026
cohort · n=2940
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →